Harrow (NASDAQ: HROW) revenue
Harrow reported revenue of $272.3m for fiscal 2025, 36.4% more than in fiscal 2024 ($199.6m). Since fiscal 2016 its revenue has grown by 1,265.5%, an average growth of 33.7% a year.
Harrow has grown its revenue for 5 years in a row, and fiscal 2025 is the highest of its 10 fiscal years on record. The biggest drop was in fiscal 2020, −4.5%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $272.3m | +36.4% | $30.5m | 11.2% |
| 2024 | $199.6m | +53.3% | $8.8m | 4.4% |
| 2023 | $130.2m | +47.0% | $0.4m | 0.3% |
| 2022 | $88.6m | +22.2% | $1.9m | 2.2% |
| 2021 | $72.5m | +48.3% | $1.6m | 2.2% |
| 2020 | $48.9m | −4.5% | $0.4m | 0.8% |
| 2019 | $51.2m | +23.7% | −$4.8m | −9.4% |
| 2018 | $41.4m | +54.5% | −$5.2m | −12.6% |
| 2017 | $26.8m | +34.3% | −$12.2m | −45.4% |
| 2016 | $19.9m | — | −$15.9m | −79.6% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Harrow revenue compared with its sector
By revenue for its latest fiscal year, Harrow ranks 227th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Harrow, 36.4%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 225th | Adaptive Biotechnologies | $277.0m | 54.8% |
| 226th | Vericel | $276.3m | 16.5% |
| 227th | Harrow | $272.3m | 36.4% |
| 228th | Viemed Healthcare | $270.3m | 20.5% |
| 229th | Ligand Pharmaceuticals | $268.1m | 60.4% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Harrow
- How much revenue did Harrow make in fiscal 2025?
- Harrow reported revenue of $272.3m for fiscal 2025, compared with $199.6m in fiscal 2024.
- How much has the revenue of Harrow grown?
- Between fiscal 2016 and fiscal 2025 it went from $19.9m to $272.3m: 1,265.5% more, an average growth of 33.7% a year.
- What was the best year for revenue at Harrow?
- Of its last 10 fiscal years, fiscal 2025, with $272.3m.
- Where does Harrow rank in its sector by revenue?
- It ranks 227th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Harrow come from?
- From the annual report (Form 10-K) that Harrow files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Harrow files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Harrow: the Harrow page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.